Form 4: Select Medical Executive Receives Significant Restricted Stock Grant

Select Medical Holdings Corp's Executive Vice President, Martin F. Jackson, was granted 150,000 shares of restricted common stock, aligning executive interests with shareholder value.

Summary

• Martin F. Jackson, Executive Vice President of Select Medical Holdings Corp (SEM), was granted 150,000 shares of common stock.
• The restricted stock grant was made at a price of $0 per share.
• The granted shares will vest in equal annual installments over a period of three years.
• Following this transaction, Mr. Jackson directly beneficially owns 1,412,881 shares of common stock.
• Additionally, Mr. Jackson indirectly beneficially owns 10,536 shares of common stock through his children (three sons and one daughter), though he disclaims beneficial ownership except to the extent of his pecuniary interest.

Sentiment

Score: 7

Explanation: The grant of restricted stock to a key executive is a positive signal, indicating management retention and alignment of interests with shareholders, though it is a standard compensation event rather than a significant operational or financial breakthrough.

Positives

• The grant of 150,000 shares of restricted stock to a key executive aligns management's long-term interests with those of shareholders.
• Restricted stock grants are a common form of executive compensation, signaling confidence in the executive's continued contribution to the company.

Future Outlook

The restricted stock grant, vesting over three years, indicates a commitment to retaining the Executive Vice President and aligns his future performance with the company's long-term success.

Industry Context

Executive compensation packages, including restricted stock grants, are standard practice across the healthcare services industry to attract, retain, and incentivize top talent. This grant is consistent with typical compensation structures aimed at aligning executive and shareholder interests.

Comparison to Industry Standards

• Restricted stock grants are a widely adopted compensation mechanism in the healthcare sector, similar to practices observed at companies like HCA Healthcare, Universal Health Services, and Tenet Healthcare, which frequently utilize equity awards to incentivize their senior leadership.
• The three-year vesting schedule is a common industry standard for such grants, promoting long-term executive retention and performance alignment.

Related Party Transactions

• The filing notes indirect beneficial ownership of shares by the reporting person's sons and daughter, with a disclaimer of beneficial ownership except for pecuniary interest.

Stakeholder Impact

• Shareholders: The grant aligns the executive's financial interests with the company's long-term performance, potentially benefiting shareholder value.
• Employees: Signals stability in executive leadership and a commitment to retaining key personnel.
• Executive: Provides significant equity compensation, incentivizing continued dedication and performance.

Next Steps

• The restricted stock will vest in equal annual installments over the next three years, contingent on the executive's continued employment.

Key Dates

Recommendation

While the restricted stock grant is a positive signal of executive alignment and retention, a single Form 4 filing typically does not warrant a strong buy or sell recommendation. It reinforces a 'hold' stance by indicating stable corporate governance and executive commitment.

Keywords

Select Medical Holdings Corp, SEM, Martin F. Jackson, Executive Vice President, Restricted Stock Grant, Executive Compensation, Insider Ownership, Form 4, Beneficial Ownership